Incyte Corporation has named Herve Hoppenot, former president of Novartis Oncology, as president and CEO. Mr. Hoppenot, who also will join the Incyte Board of Directors, succeeds Paul A. Friedman, M.D. Dr. Friedman is retiring and will continue to serve on the Board.